Validation of SMS Protocol for HCC Screening in High-risk Patients

Bi-annual, non-contrast agents, MRI screening consisting of Diffusion Weighted Imaging (b-values of 50 and 800 s/mm2), T2-weighted imaging and T1-weighted in- and out-of-phase imaging

Bi-annual ultrasonography for screening of HCC in high-risk patients